Fezagepras
Fezagepras (Setogepram) is an orally bioavailable small molecule that acts as a GPR40 agonist and a GPR84 antagonist/inverse agonist. It exhibits anti-inflammatory, anti-fibrotic, and anti-proliferative properties, making it a useful research tool for studying metabolic and inflammatory diseases in both in vitro and in vivo models.
Product Specifications
CAS Number
1002101-19-0
Product Name Alternative
Diabetes, Kidney, Renal, Pancreatic, Liver, Fibrosis, Nephrology, inhibit, PBI4050, PBI-4050, PBI 4050, Inhibitor, G protein coupled receptor 84, Free Fatty Acid Receptor, Fezagepras, FFAR, GPR40, GPR84, Setogepram
Field of Research
Metabolism Research, Pharmacology & Drug Discovery
Purity
96.73% (May vary between batches)
Solubility
DMSO:60 mg/mL (290.87 mM) ;10% DMSO+90% Saline:5 mg/mL (24.24 mM)
Smiles
CCCCCc1cccc (CC (O) =O) c1
Molecular Formula
C13H18O2
Molecular Weight
206.28
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog